Why AC Immune Stock Surged Today

What happenedShares of AC Immune (NASDAQ: ACIU) jumped 15% on Thursday after the Swiss-based biopharmaceutical company released promising data from its early-stage study of ACI-35.030, an experimental vaccine for the treatment of Alzheimer’s disease (AD).Read MoreMarketsMarkets Feed